St. Judes combined OCT, FFR platform gets EU nod

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

St. Jude Medical has received European CE Mark approval for its Ilumien system, a diagnostic technology that combines optical coherence tomography (OCT) and fractional flow reserve (FFR) technologies on one platform.

The combined system offers physicians physiological and anatomical readings for the diagnosis and treatment of coronary artery disease, according to the St. Paul, Minn.-based company.

The Ilumien system features St. Jude’s PressureWire Aeris, a wireless interventional tool that measures FFR to evaluate the severity of blood flow blockages in the coronary arteries, and St. Jude’s C7-XR OCT diagnostic imaging technology with Extreme Resolution, an intravascular imaging technology that allows physicians to visualize and measure vessel characteristics.

In addition, the Ilumien system features the Wi-Box, a wireless device that enables the Ilumien system to receive data (aortic pressure readings) from the catheterization lab wirelessly. The Wi-Box allows physicians and staff a cable-free FFR technology.

The C7-XR System with the C7 Dragonfly imaging catheter and the PressureWire Aeris were launched in Europe in 2009.